Guardian Capital Advisors LP Sanofi Transaction History

Guardian Capital Advisors LP

$967 Million
Q3 2024

A detailed history of Guardian Capital Advisors LP transactions in Sanofi stock. As of the latest transaction made, Guardian Capital Advisors LP holds 183,054 shares of SNY stock, worth $9.97 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares

183,054

Previous 182,069 0.54%

Holding current value

$9.97 Million

Previous $8.83 Million 19.48%

% of portfolio

1.09%

Previous 1.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$48.54 - $58.53 $47,811 - $57,652	985 Added 0.54%	183,054 $10.6 Million
Q2 2024 Aug 13, 2024	BUY	$45.39 - $50.36 $287,954 - $319,483	6,344 Added 3.61%	182,069 $8.83 Million
Q1 2024 May 14, 2024	SELL	$45.75 - $52.48 $34,587 - $39,674	-756 Reduced 0.43%	175,725 $8.54 Million
Q4 2023 Feb 08, 2024	SELL	$43.13 - $54.79 $486,118 - $617,538	-11,271 Reduced 6.0%	176,481 $8.78 Million
Q3 2023 Nov 13, 2023	SELL	$50.95 - $55.2 $74,896 - $81,144	-1,470 Reduced 0.78%	187,752 $10.1 Million
Q2 2023 Aug 14, 2023	SELL	$50.45 - $57.18 $220,718 - $250,162	-4,375 Reduced 2.26%	189,222 $10.2 Million
Q1 2023 May 15, 2023	SELL	$45.86 - $54.45 $75,439 - $89,570	-1,645 Reduced 0.84%	193,597 $10.5 Million
Q4 2022 Feb 14, 2023	SELL	$38.86 - $48.55 $13,018 - $16,264	-335 Reduced 0.17%	195,242 $9.46 Million
Q3 2022 Nov 14, 2022	BUY	$37.22 - $100.5 $392,857 - $1.06 Million	10,555 Added 5.7%	195,577 $7.67 Million
Q2 2022 Aug 12, 2022	SELL	$48.99 - $57.46 $89,553 - $105,036	-1,828 Reduced 0.98%	185,022 $9.15 Million
Q1 2022 May 16, 2022	BUY	$48.48 - $53.65 $96,378 - $106,656	1,988 Added 1.08%	186,850 $10.4 Million
Q4 2021 Feb 10, 2022	BUY	$47.07 - $52.35 $126,147 - $140,298	2,680 Added 1.47%	184,862 $9.52 Million
Q3 2021 Nov 15, 2021	BUY	$47.89 - $53.12 $283,508 - $314,470	5,920 Added 3.36%	182,182 $8.81 Million
Q2 2021 Aug 17, 2021	BUY	$49.36 - $54.25 $409,934 - $450,546	8,305 Added 4.94%	176,262 $9.23 Million
Q1 2021 May 17, 2021	BUY	$45.46 - $50.51 $151,836 - $168,703	3,340 Added 2.03%	167,957 $8.44 Million
Q4 2020 Feb 12, 2021	BUY	$45.3 - $51.62 $192,978 - $219,901	4,260 Added 2.66%	164,617 $8.02 Million
Q3 2020 Nov 16, 2020	BUY	$49.47 - $53.77 $26,219 - $28,498	530 Added 0.33%	160,357 $8.2 Million
Q2 2020 Aug 13, 2020	BUY	$42.91 - $52.5 $285,995 - $349,912	6,665 Added 4.35%	159,827 $5.98 Million
Q1 2020 May 15, 2020	BUY	$38.02 - $51.66 $114,098 - $155,031	3,001 Added 2.0%	153,162 $4.62 Million
Q4 2019 Feb 13, 2020	BUY	$44.25 - $50.86 $51,330 - $58,997	1,160 Added 0.78%	150,161 $7.66 Million
Q3 2019 Nov 14, 2019	BUY	$40.34 - $46.64 $200,288 - $231,567	4,965 Added 3.45%	149,001 $6.59 Million
Q2 2019 Aug 14, 2019	BUY	$40.43 - $44.3 $72,571 - $79,518	1,795 Added 1.26%	144,036 $6.34 Million
Q1 2019 May 15, 2019	BUY	$40.83 - $45.43 $59,693 - $66,418	1,462 Added 1.04%	142,241 $5.88 Million
Q4 2018 Feb 13, 2019	BUY	$41.48 - $45.59 $69,893 - $76,819	1,685 Added 1.21%	140,779 $5.86 Million
Q3 2018 Nov 13, 2018	BUY	$40.0 - $44.84 $55,200 - $61,879	1,380 Added 1.0%	139,094 $6.06 Million
Q2 2018 Aug 14, 2018	BUY	$37.63 - $41.22 $179,495 - $196,619	4,770 Added 3.59%	137,714 $5.75 Million
Q1 2018 May 15, 2018	BUY	$38.98 - $45.76 $236,608 - $277,763	6,070 Added 4.78%	132,944 $5.39 Million
Q4 2017 Feb 14, 2018	BUY	$42.86 - $50.61 $218,800 - $258,364	5,105 Added 4.19%	126,874 $5.66 Million
Q3 2017 Nov 15, 2017	BUY	$47.04 - $50.34 $45,158 - $48,326	960 Added 0.79%	121,769 $6.03 Million
Q2 2017 Aug 14, 2017	BUY	N/A	120,809	120,809 $5.88 Million

Others Institutions Holding SNY

# of Institutions

800

Shares Held

266M

Call Options Held

1.82M

Put Options Held

1.64M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $137B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Capital Advisors LP with notifications on news.

Account

Guardian Capital Advisors LP Sanofi Transaction History